(Generic versions may still be available.)
Based on a review of this drug by the National Academy of Sciences —National Research Council and/or other information, FDA has classified the indications as follows:
“Possibly” effective: as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.
Final classification of the less-than-effective indications requires further investigation.
DOSAGE AND ADMINISTRATION
Because of the varied individual responses to tranquilizers and anticholinergics, the optimum dosage of Librax (chlordiazepoxide and clidinium) varies with the diagnosis and response of the individual patient. The dosage, therefore, should be individualized for maximum beneficial effects. The usual maintenance dose is 1 or 2 capsules, 3 or 4 times a day administered before meals and at bedtime.
Dosage should be limited to the smallest effective amount to preclude the development of ataxia, oversedation or confusion. The initial dose should not exceed 2 Librax (chlordiazepoxide and clidinium) capsules per day, to be increased gradually as needed and tolerated.
Librax (chlordiazepoxide and clidinium) is available in green capsules, each containing 5 mg chlordiazepoxide hydrochloride and 2.5 mg clidinium bromide — bottles of 100 (NDC 0187-4100-10).
Valeant Pharmaceuticals International, Costa Mesa, CA92626. Rev. Jun. 05.
Last reviewed on RxList: 3/18/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Librax Information
Librax - User Reviews
Librax User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Get the latest treatment options.